Regeneron Pharmaceuticals (REGN) Q1 2017 Earnings

9FebConfirmed
Q2 2016
Q3 2016
Q4 2016
Q1 2017
2.39
2.64
2.88
3.13

Details

Expected EPS
3.1
Actual EPS
3.04
Surprise EPS
-0.06
Surprise Percent
+1.94%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 3.04 per share for Q1 2017.

0 Comments

Share your thoughts